Skip to main navigation
Skip to search
Skip to main content
Universidad de los Andes Home
English
Español
Home
Profiles
Research units
Research output
Projects
Press/Media
Activities
Equipment
Student theses
Prizes
Courses
Impacts
Search by expertise, name or affiliation
Treatment with cyclosporine of refractory rheumatoid arthritis
L. Massardo
, S. Jacobelli
,
F. Figueroa
, F. Gutiérrez
, M. E. Martínez
, S. Rivero
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment with cyclosporine of refractory rheumatoid arthritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cyclosporine
100%
Refractory Rheumatoid Arthritis
100%
Blood Pressure
75%
Creatinine
50%
Maximum Tolerated Dose
50%
Immunosuppressive Agents
50%
Clinical Response
50%
Rheumatoid Arthritis
25%
Rheumatoid Arthritis Treatment
25%
Hepatic Toxicity
25%
Initial Dose
25%
In(III)
25%
Serum Creatinine
25%
Patient-completed
25%
Prolonged Use
25%
Secondary Effects
25%
Anti-inflammatory Drugs
25%
Concomitant Administration
25%
Blood Serum
25%
Nursing and Health Professions
Ciclosporin
100%
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Maximum Permissible Dose
50%
Blood Pressure
50%
Immunosuppressive Agent
50%
Creatinine
50%
Antiinflammatory Agent
25%
Creatinine Blood Level
25%
Elevated Blood Pressure
25%
Medicine and Dentistry
Cyclosporine
100%
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Creatinine
75%
Blood Pressure
50%
Immunosuppressive Drug
50%
Antiinflammatory Agent
25%
Elevated Blood Pressure
25%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Ciclosporin
100%
Inflammatory Arthritis
100%
Creatinine
75%
Immunosuppressive Agent
50%
Elevated Blood Pressure
25%
Antiinflammatory Agent
25%
Immunology and Microbiology
Inflammatory Arthritis
100%
Ciclosporin
100%
Blood Pressure
75%
Immunosuppressive Drug
50%
Maximum Permissible Dose
50%
Serum (Blood)
25%